Papers: 10.1371/journal.pone.0252665

https://doi.org/10.1371/journal.pone.0252665

Phase II trial of cisplatin, gemcitabine and pembrolizumab for platinum-resistant ovarian cancer

Cited by: 13
Author(s): Christine Walsh, Mitchell Kamrava, André Rogatko, Sungjin Kim, Andrew Li, Ilana Cass, Beth Y. Karlan, B.J. Rimel
Published: over 5 years ago

Software Mentions 1